Inhibition of ornithine decarboxylase induces embryonal carcinoma cell differentiation.
Murine embryonal carcinoma cells can be induced to differentiate in vitro by various physical and chemical means. We report here that inhibition of ornithine decarboxylase activity with a specific enzyme-activated inhibitor, alpha-difluoromethylornithine, can induce differentiation in embryonal carcinoma cells. The differentiated phenotype can be distinguished from undifferentiated embryonal carcinoma cells by altered cellular morphology, biochemical and cell surface antigenic properties. These results suggest that alterations in the levels of cellular polyamines may play a role in embryonal carcinoma cell differentiation.
D000818:Animals; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors*; D002454:Cell Differentiation / Q000187:drug effects; D002460:Cell Line; D000518:Eflornithine; D051379:Mice; D009374:Neoplasms, Experimental / Q000503:physiopathology; D009952:Ornithine / Q000031:analogs & derivatives* / Q000494:pharmacology; D065108:Ornithine Decarboxylase Inhibitors; D011700:Putrescine / Q000032:analysis; D013095:Spermidine / Q000032:analysis; D013096:Spermine / Q000032:analysis; D013724:Teratoma / Q000503:physiopathology*
D065108:Ornithine Decarboxylase Inhibitors; D013096:Spermine; D009952:Ornithine; D002262:Carboxy-Lyases; D013095:Spermidine; D011700:Putrescine; D000518:Eflornithine